Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
CT three-dimensional reconstruction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rectal Cancer
1 trial -
Carbon Nanoparticle Suspension Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
Celebrex
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial -
Celecoxib 400mg
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Peutz-Jeghers Syndrome
1 trial -
Chidamide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
AML
1 trial -
Chidamide
Hospital Authority, Hong Kong
AML
1 trial -
Chinese herbs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Depression
1 trial -
Cholecalciferol
United Therapeutics Europe Ltd
Vitamin D Deficiency
1 trial -
Ciprofol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sedation
1 trial -
Citalopram
COGNITION THERAPEUTICS INC
Antidepressive Agents, Second-Generation
1 trial -
Clarithromycin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Rhinosinusitis
1 trial -
Coenzyme Q10
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Disease
1 trial -
Cognitive behavioral therapy for anxiety plus benzodiazepine taper
BRIGHT MINDS BIOSCIENCES INC.
Anxiety Disorders
1 trial -
Colchicine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Transcatheter Aortic Valve Replacement
1 trial -
Compound Norethisterone Enanthate Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Contraception Behavior
1 trial -
Computer Aided Diagnosis
Chinese University of Hong Kong
Upper Gastrointestinal Disorder
1 trial -
Conservative treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Pancreatitis
1 trial -
Contrast-enhanced ultrasound-guided core biopsy
The First People's Hospital of Lianyungang
Pancreatic Disease
1 trial -
Control lidocaine cream
The First People's Hospital of Lianyungang
Atopic Dermatitis
1 trial -
Conventional treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Copd Exacerbation Acute
1 trial -
Cordyceps cicadae
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Visual Acuity
2 trials -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Statin
1 trial -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Primary Prevention Strategy
1 trial -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Major Adverse Cardiovascular Events (MACE)
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources